Skip to main content
. 2011 Nov;52(11):1965–1973. doi: 10.1194/jlr.M016410

Fig.4.

Fig.4.

Changes in HDL cholesterol composition with anacetrapib treatment. A: Increase in HDL total cholesterol is more prominent in large HDL fraction; B: majority of increase driven by free cholesterol and cholesteryl linoleate (18:2). *P < 0.05, **P < 0.01, ***P < 0.001 versus vehicle.